Pharma Calls Out One of its Own

It’s not often that an association publicly disagrees with someone in the industry it represents. But the uproar over Turing Pharmaceuticals CEO Martin Shkreli jacking up the price of a life-saving drug 4,000% prompted this tweet from the Pharmaceutical Research and Manufacturers of America. The organization has been known to protect its own during a controversy, but in this case, the CEO’s unapologetic public comments hit a nerve. The tweet inspired even more backlash from people questioning why drugs are so expensive. [WaPo]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Washington, D.C. Newsletters
Related Stories

Why Top-Secret Facilities Are Permeating Greater D.C.'s Office Market

Downtown Atlanta Improvement Group Picks Food Bank Chief As Next Leader

Northern Virginia Office Tower Sells For Double Its 2024 Price

Design Plans Revealed For RFK Stadium Parking Garages, Headed To Review

Security Tech Firm Plans Loudoun HQ Move: The D.C. Deal Sheet

D.C. Investor Behind The Stacks Swaps CEO For First Time In 25 Years

Pennsylvania Avenue Office Sells For Repositioning: The D.C. Deal Sheet

Georgetown Waterfront Office-To-Condo Conversion Lands Financing

Westfield Montgomery Pays Off $350M Loan As New Retailers Expand In Mall

Tishman Misses Payment Deadline On $450M International Square Loan

Real Estate Firm Debuts With $126M Purchase Of Historic D.C. Building

Surging Costs Force Alexandria Developers To Shift Plans